Covetrus Inc. (CVET)
Company Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company.
It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners.
In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics.
Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services.
It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific.
The company was formerly known as HS Spinco, Inc.
Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
As of October 13, 2022, Covetrus, Inc. was taken private.

Country | United States |
IPO Date | Feb 4, 2019 |
Industry | Medical - Distribution |
Sector | Healthcare |
Employees | 4,035 |
CEO | Benjamin Wolin |
Contact Details
Address: 7 Custom House St Portland, MAINE United States | |
Website | https://www.covetrus.com |
Stock Details
Ticker Symbol | CVET |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001752836 |
CUSIP Number | 22304C100 |
ISIN Number | US22304C1009 |
Employer ID | 83-1448706 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Benjamin Wolin | Pres, Chief Executive Officer & Director |
Matthew J. Foulston | Executive Vice President & Global Chief Financial Officer |
Michelle Bonfilio | Chief People Officer |
Andrew B. Coxhead | Vice President, Corporation Controller & Chief Accounting Officer |
Cameron R. Foster | Senior Vice President of Strategy & Corporation Devel. |
Georgina Wraight | Executive Vice President & Pres of Global Technology Solutions |
Margie B. Pritchard | Gen. Counsel & Corporation Sec. |
Matthew Malenfant | Chief Commercial Officer |
Nicholas Michael Jansen | Vice President of Investor Relations |
Rebecca Kidd | Head of Operations & Operational Excellence |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 24, 2022 | 15-12G | Filing |
Oct 13, 2022 | SC 13D/A | [Amend] Filing |
Oct 13, 2022 | 4 | Filing |
Oct 13, 2022 | S-8 POS | Filing |
Oct 13, 2022 | SC 13E3/A | [Amend] Filing |
Oct 13, 2022 | 8-K | Current Report |
Oct 13, 2022 | 4 | Filing |
Oct 13, 2022 | 4 | Filing |
Oct 13, 2022 | 4 | Filing |
Oct 13, 2022 | 4 | Filing |